A lead investigator presented clinical trial findings involving Eli Lilly at the American Diabetes Association sessions.
1 report, 1 independent
Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A lead investigator presented clinical trial findings involving Eli Lilly at the American Diabetes Association sessions.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
American Diabetes Association
U.S.-based nonprofit organization
Related events
- Eli Lilly and Company has achieved market leadership in the obesity and diabetes treatments sector.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- A senior research scientist from Eli Lilly and Company is presenting abstracts at the AAIC conference in London.
- Eli Lilly and Novo Nordisk are now competing in the basal insulin market segment.
- Eli Lilly's obesity and diabetes drug pipeline is cited as a driver of market growth.